-
Tytuł:
-
Clinical characteristics of non-intensive care unit COVID-19 patients in Saudi Arabia: A descriptive cross-sectional study.
-
Autorzy:
-
Al-Omari A; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Alhuqbani WN; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia; College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Zaidi ARZ; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia. Electronic address: .
Al-Subaie MF; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
AlHindi AM; College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Abogosh AK; College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alrasheed AK; College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alsharafi AA; College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alhuqbani MN; College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Salih S; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia.
Alhedaithy MA; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia.
Abdulqawi R; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Ismail AF; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia.
Alhumaid S; Ministry of Health, Riyadh, Saudi Arabia.
Hamdan N; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia.
Saad F; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia.
Olhaye FA; Internal Medicine Department, Al Hammadi Hospital, Riyadh, Saudi Arabia.
Eltahir TA; Internal Medicine Department, Al Hammadi Hospital, Riyadh, Saudi Arabia.
Alomari M; Palliative Care Department, King Fahad Medical City, Riyadh, Saudi Arabia.
Alshehery M; Palliative Care Department, King Fahad Medical City, Riyadh, Saudi Arabia.
Yassiri A; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia.
Al-Tawfiq JA; Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Al Mutair A; Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia; Wollongong University, Australia. Electronic address: .
-
Źródło:
-
Journal of infection and public health [J Infect Public Health] 2020 Nov; Vol. 13 (11), pp. 1639-1644. Date of Electronic Publication: 2020 Sep 21.
-
Typ publikacji:
-
Journal Article
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: Oxford : Elsevier, 2008-
-
MeSH Terms:
-
Qualitative Research*
Coronavirus Infections/*epidemiology
Hospitalization/*statistics & numerical data
Pneumonia, Viral/*epidemiology
Adolescent ; Adult ; Age Factors ; Aged ; Betacoronavirus ; COVID-19 ; Child ; Child, Preschool ; Comorbidity ; Coronavirus Infections/prevention & control ; Cross-Sectional Studies ; Female ; Fever/epidemiology ; Fever/virology ; Humans ; Infant ; Infant, Newborn ; Intensive Care Units ; Male ; Middle Aged ; Pandemics/prevention & control ; Pneumonia, Viral/prevention & control ; Retrospective Studies ; SARS-CoV-2 ; Saudi Arabia/epidemiology ; Young Adult
-
References:
-
Nature. 2020 Mar;579(7798):270-273. (PMID: 32015507)
Clin Rev Allergy Immunol. 2019 Jun;56(3):308-321. (PMID: 28963611)
Emerg Infect Dis. 2020 Jun;26(6):1337-1339. (PMID: 32150527)
J Infect. 2020 Aug;81(2):e16-e25. (PMID: 32335169)
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388. (PMID: 32275452)
J Am Soc Nephrol. 2020 Jul;31(7):1380-1383. (PMID: 32366514)
Front Genet. 2014 Jun 19;5:187. (PMID: 24995013)
Int J Infect Dis. 2016 Aug;49:129-33. (PMID: 27352628)
Clin Chest Med. 2001 Dec;22(4):759-67. (PMID: 11787663)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Thorax. 2003 Aug;58(8):686-9. (PMID: 12885985)
Lancet. 2020 May 16;395(10236):1544-1545. (PMID: 32380044)
JAMA. 2020 Apr 7;323(13):1313-1314. (PMID: 32058570)
J Infect. 2020 Jun;80(6):e14-e18. (PMID: 32171866)
Diagnosis (Berl). 2020 May 26;7(2):91-96. (PMID: 32352401)
J Infect Dev Ctries. 2020 Feb 29;14(2):125-128. (PMID: 32146445)
Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145)
Clin Microbiol Rev. 2015 Apr;28(2):465-522. (PMID: 25810418)
N Engl J Med. 2020 Mar 26;382(13):1199-1207. (PMID: 31995857)
Front Immunol. 2019 May 10;10:1071. (PMID: 31134099)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
Am J Gastroenterol. 2020 Jun;115(6):916-923. (PMID: 32301761)
J Immunol. 2017 May 15;198(10):4046-4053. (PMID: 28373583)
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. (PMID: 32232218)
Pediatrics. 2020 Jun;145(6):. (PMID: 32179660)
J Infect Public Health. 2020 Jul;13(7):920-925. (PMID: 32534945)
Sci Adv. 2017 Nov 15;3(11):eaao4966. (PMID: 29152574)
JAMA. 2020 May 12;323(18):1775-1776. (PMID: 32203977)
J Infect Public Health. 2020 Jul;13(7):906-913. (PMID: 32546437)
BMC Med. 2020 Feb 28;18(1):57. (PMID: 32106852)
BMJ. 2020 May 22;369:m1985. (PMID: 32444460)
-
Contributed Indexing:
-
Keywords: COVID-19; Clinical characteristics; Comorbidities; SARS-CoV-2; Saudi Arabia; Symptoms
-
Entry Date(s):
-
Date Created: 20201002 Date Completed: 20201116 Latest Revision: 20210110
-
Update Code:
-
20240105
-
PubMed Central ID:
-
PMC7505603
-
DOI:
-
10.1016/j.jiph.2020.09.003
-
PMID:
-
33004305
-
Introduction: The ongoing pandemic of the coronavirus disease 2019 (COVID-19) is a global health concern. It has affected more than 5 million patients worldwide and resulted in an alarming number of deaths globally. While clinical characteristics have been reported elsewhere, data from our region is scarce. We investigated the clinical characteristics of mild to moderate cases of COVID-19 in Saudi Arabia.
Methods: This is a descriptive, cross-sectional study. Data of 401 confirmed COVID-19 patients were collected from 22 April 2020 to 21 May 2020 at five tertiary care hospitals in Riyadh, Saudi Arabia. The patients were divided into four groups according to age, Group 1: 0-<18 years, Group 2: 18-<50 years, Group 3: 50-60 years, and Group 4: >60 years; and their clinical symptoms were compared.
Results: The median (IQR) age in years was 10.5 (1.5-16) in group I, 34 (29-41) in group II, 53 (51-56) in group III, and 66 (61-76) in group IV. Most patients were male (80%, n = 322) and of Arabian or Asian descent. The median length of stay in the hospital was 10 (8-17) days (range 3-42 days). The most common symptoms were cough (53.6%), fever (36.2%), fatigue (26.4%), dyspnea (21.9%), and sore throat (21.9%). Hypertension was the most common underlying comorbidity (14.7%), followed by obesity (11.5%), and diabetes (10%). Hypertensive patients were less likely to present with shortness of breath, cough, sputum, diarrhea, and fever.
Conclusion: There was no significant difference in the symptoms among different age groups and comorbidities were mostly seen in the older age group. Interestingly, hypertensive patients were found to have milder symptoms and a shorter length of stay. Further larger collaborative national studies are required to effectively understand clinical characteristics in our part of the world to efficiently manage and control the spread of SARS-CoV-2.
(Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
